🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China flag China · Delayed Price · Currency is CNY
32.95
-1.74 (-5.02%)
Nov 20, 2026, 3:04 PM CST

SHE:300573 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,7872,4531,9241,4401,2271,024
Other Revenue
19.9219.9219.4927.8623.23.6
2,8072,4731,9431,4681,2501,028
Revenue Growth
16.57%27.24%32.42%17.42%21.59%49.26%
Cost of Revenue
509.36477.94424.53340.36270.08229.01
Gross Profit
2,2971,9951,5191,127979.78798.91
Selling, General & Admin
1,036938.52875.78689.8595.39456.54
Research & Development
303.6225.91220.66167.3145.6188.45
Other Operating Expenses
42.2818.9210.687.166.6613.8
Operating Expenses
1,3811,1841,110867.29748.58558.6
Operating Income
916.16810.48408.42259.93231.2240.31
Interest Expense
-1.75-4.44-5.71-1.44-0.94-5.99
Interest & Investment Income
6.212.255.667.919.933.98
Currency Exchange Gain (Loss)
-1.67-1.67-0.110.2-0.09-0.13
Other Non Operating Income (Expenses)
-10.19-1.49-2.11-1.15-19.31-1.05
EBT Excluding Unusual Items
908.75805.14406.15265.45220.79237.12
Gain (Loss) on Sale of Investments
---0.02---
Gain (Loss) on Sale of Assets
-0.020.05-0.98-0.040.425.16
Asset Writedown
2.69-3.7-14.05--0-0
Other Unusual Items
7.13-1.223.94-0.4212.511.26
Pretax Income
918.55800.28395.03264.99233.72243.54
Income Tax Expense
116.5104.4256.9724.9622.0334.43
Earnings From Continuing Operations
802.06695.86338.06240.04211.68209.11
Minority Interest in Earnings
------14.41
Net Income
802.06695.86338.06240.04211.68194.7
Net Income to Common
802.06695.86338.06240.04211.68194.7
Net Income Growth
24.12%105.84%40.84%13.39%8.72%121.31%
Shares Outstanding (Basic)
356357355353350324
Shares Outstanding (Diluted)
358357355353350325
Shares Change
0.21%0.37%0.60%0.95%7.46%-0.31%
EPS (Basic)
2.251.950.950.680.610.60
EPS (Diluted)
2.241.950.950.680.610.60
EPS Growth
23.86%105.08%40.00%12.33%1.17%120.43%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
613.91482.86218.2755.61-12.96211.9
Free Cash Flow Per Share
1.721.350.610.16-0.040.65
Dividend Per Share
0.9901.1720.7391.3020.3770.163
Dividend Growth
1.46%58.67%-43.24%245.33%130.72%160.19%
Gross Margin
81.85%80.67%78.16%76.81%78.39%77.72%
Operating Margin
32.64%32.77%21.02%17.71%18.50%23.38%
Profit Margin
28.58%28.14%17.39%16.36%16.94%18.94%
Free Cash Flow Margin
21.87%19.53%11.23%3.79%-1.04%20.61%
EBITDA
1,022911.51502.42340.3297.23297.55
EBITDA Margin
36.43%36.86%25.85%23.19%23.78%28.95%
D&A For EBITDA
106.32101.049480.3866.0357.24
EBIT
916.16810.48408.42259.93231.2240.31
EBIT Margin
32.64%32.77%21.02%17.71%18.50%23.38%
Effective Tax Rate
12.68%13.05%14.42%9.42%9.43%14.14%
Revenue as Reported
2,8072,4731,9431,4681,2501,028
Advertising Expenses
---13.81135.22